Lupus Therapeutic Market Demand, Insights and Forecast Up to 2029
Data Bridge Market Research analyses that the Lupus Therapeutic Market was valued at USD 2,562.05 million in 2021 and is expected to reach USD 5,142.63 million by 2029, registering a CAGR of 9.10% during the forecast period of 2022 to 2029.
Industry Analysis
In recent years, the lupus therapeutic market is
anticipated to grow rapidly during the forecast period. The Lupus Foundation of
America estimates that 1.5 million Americans have lupus, with 16,000 new cases
recorded each year in the Americas. Lupus is a chronic autoimmune
illness in which the immune system of the body fails to identify its own cells
and tissues and attacks them. Your immune system attacks your skin in cutaneous
(skin) lupus. Skin lupus affects about 10% of all lupus cases, while skin lupus
affects 65 percent of patients with systemic lupus. The market report curated
by the Data Bridge Market Research team includes in-depth expert analysis,
patient epidemiology, pipeline analysis, pricing analysis, and regulatory
framework.
Lupus is an autoimmune inflammatory condition in which
the body's immune system becomes overactive and begins attacking healthy
tissues. Swelling, inflammation, skin rashes, and joint discomfort are all
common signs and symptoms of lupus. Lupus therapies are a type of therapeutic
that is often used to treat lupus illnesses.
Global Lupus
Therapeutic Market Scope
The lupus
therapeutic market is segmented on the basis of type, treatment, diagnosis,
route of administration, end-users and distribution channel. The growth amongst
these segments will help you analyze meagre growth segments in the industries
and provide the users with a valuable market overview and market insights to
help them make strategic decisions for identifying core market applications.
Type
·
Systemic Lupus Erythematosus (SLE)
·
Cutaneous Lupus Erythematosus,
·
Drug-Induced Lupus Erythematosus
·
Neonatal Lupus
Treatment
·
Immunosuppressive Drugs
·
Biologic Drugs
·
Antihypertensive Drugs
·
Others
Diagnosis
·
Laboratory Tests
·
Antinuclear antibody (ANA) test
·
Urinalysis
·
Kidney and liver assessment
·
Erythrocyte sedimentation rate
·
Complete blood count
·
Biopsy
·
Imaging Tests
·
Echocardiogram
·
Chest X-ray
·
Others
Route of
Administration
·
Oral
·
Parenteral
·
Others
End-Users
·
Specialty Clinics
·
Homecare
·
Others
Distribution
Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
·
Others
Get the sample copy of the report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lupus-therapeutic-market
Lupus
Therapeutic Market Regional Analysis/Insights
The Lupus therapeutic market is analysed and market
size insights and trends are provided by country, type, treatment, diagnosis,
route of administration, end-users and distribution channel as referenced
above.
The countries
covered in the Lupus Therapeutic Market report are the
·
U.S.
·
Canada
and Mexico in North America
·
Germany
·
France
·
U.K.
·
Netherlands
·
Switzerland
·
Belgium
·
Russia
·
Italy
·
Spain
·
Turkey
·
Rest
of Europe in Europe
·
China
·
Japan
·
India
·
South
Korea
·
Singapore
·
Malaysia
·
Australia
·
Thailand
·
Indonesia
·
Philippines
·
Rest
of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
·
Saudi
Arabia
·
U.A.E
·
South
Africa
·
Egypt
·
Israel
·
Rest
of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
·
Brazil
·
Argentina
and Rest of South America as part of South America.
Competitive
Landscape and Lupus Therapeutic Market Share Analysis
The Lupus therapeutic market competitive landscape
provides details by competitor. Details included are company overview, company
financials, revenue generated, market potential, investment in research and
development, new market initiatives, global presence, production sites and
facilities, production capacities, company strengths and weaknesses, product
launch, product width and breadth, application dominance. The above data points
provided are only related to the companies' focus related to lupus therapeutic
market.
Some of the
major players operating in the lupus therapeutic market are:
·
LEO Pharma A/S (Denmark)
·
Zydus Cadila (India)
·
Amneal Pharmaceuticals LLC. (US)
·
Glenmark Pharmaceuticals Limited
(India)
·
Hikma Pharmaceuticals PLC (UK)
·
Dr. Reddy’s Laboratories Ltd.
(India)
·
AstraZeneca (UK)
·
Johnson & Johnson Private
Limited (US)
·
Bausch Health Companies Inc.
(Canada)
·
Eli Lilly and Company (US)
·
AbbVie Inc. (US)
·
Abbott (US)
·
F. Hoffmann-La Roche Ltd.
(Switzerland)
·
Mylan N.V. (US)
·
Teva Pharmaceutical Industries Ltd.
(Israel)
·
Sanofi (France)
·
Novartis AG (Switzerland)
·
Sun Pharmaceutical Industries Ltd.
(India)
·
Aurobindo Pharma (India)
·
Lupin (India)
·
Allergan (Ireland)
·
Merck & Co., Inc. (US)
·
Sumitomo Corporation (Japan)
·
Pfizer Inc. (US)
·
GlaxoSmithKline plc (UK)
Get Full
Access of reports @ https://www.databridgemarketresearch.com/reports/global-lupus-therapeutic-market
MAJOR TOC OF THE REPORT
Ø Chapter One: Introduction
Ø Chapter Two: Market Segmentation
Ø Chapter Three: Market Overview
Ø Chapter Four: Executive Summary
Ø Chapter Five: Premium Insights
Ø Chapter Six: Global Lupus Therapeutic Market
by Product & Procedure type
Get TOC
Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-lupus-therapeutic-market
Browse
Related Reports @
https://www.databridgemarketresearch.com/reports/asia-pacific-pulse-protein-market
https://www.databridgemarketresearch.com/reports/global-transradial-access-market
https://www.databridgemarketresearch.com/reports/north-america-transradial-access-market
https://www.databridgemarketresearch.com/reports/europe-transradial-access-market
https://www.databridgemarketresearch.com/reports/asia-pacific-transradial-access-market
About
Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market
Contact:-
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

Comments
Post a Comment